End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
59.9 TWD | +2.22% | +7.35% | -13.56% |
Mar. 20 | CHO Pharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Aug. 09 | CHO Pharma, Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2022 | 60K 1.88K | Sales 2023 | - | Capitalization | 14.83B 464M |
---|---|---|---|---|---|
Net income 2022 | -338M -10.58M | Net income 2023 | -306M -9.58M | EV / Sales 2022 | 402,853 x |
Net cash position 2022 | 1.03B 32.32M | Net cash position 2023 | 2.6B 81.44M | EV / Sales 2023 | - |
P/E ratio 2022 |
-74.5
x | P/E ratio 2023 |
-43.3
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
1 day | +2.22% | ||
1 week | +7.35% | ||
Current month | -5.97% | ||
1 month | -6.26% | ||
3 months | -12.68% | ||
6 months | -27.39% | ||
Current year | -13.56% |
Managers | Title | Age | Since |
---|---|---|---|
Tsung I Wu
CEO | Chief Executive Officer | - | - |
Chao-Long Chen
CHM | Chairman | - | 17-12-26 |
Yi Pei Chou
DFI | Director of Finance/CFO | - | 16-03-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ming Hsing Tsai
BRD | Director/Board Member | 66 | 13-05-26 |
Hsuan Ta Liu
BRD | Director/Board Member | - | 19-06-05 |
Chao-Long Chen
CHM | Chairman | - | 17-12-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 115 M€ | +5.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 59.9 | +2.22% | 204,807 |
24-03-27 | 58.6 | -0.85% | 335,108 |
24-03-26 | 59.1 | -5.14% | 889,222 |
24-03-25 | 62.3 | -1.11% | 1,290,226 |
24-03-22 | 63 | +5.18% | 1,531,749 |
End-of-day quote Taipei Exchange, March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-13.56% | 392M | |
+0.44% | 90.27B | |
+9.61% | 44.05B | |
-16.67% | 31.45B | |
+44.99% | 23.35B | |
-9.42% | 16.72B | |
-25.92% | 15.09B | |
-9.27% | 12.82B | |
-7.57% | 11.95B | |
+0.07% | 8.71B |